DOOR TO NEEDLE TIME OF STREPTOKINASE AND ST SEGMENT RESOLUTION ASSESSING THE EFFICACY OF REPERFUSION THERAPY AT KARACHI INSTITUTE OF HEART DISEASES
Abstract
Background: Early start of treatment including coronary revascularisation has been recognised ascrucial variable in the outcome of acute ST-segment Elevation Myocardial Infarction (STEMI).Objectives of the study were to determine the magnitude of ST-segment resolution after thrombolytictherapy predicts short- and long-term outcomes in patients with an Acute Myocardial Infarction (AMI).Methods: The duration of quasi experimental study was 3 years, from July 2006 to June 2009,conducted at Karachi Institute of Heart Diseases. Total 1,023 patients of STEMI treated withstreptokinase (SK) were enrolled in the study. Result: Of the total 1023, 689 (67.3%) patients weremales and 334 (32.6%) were females. Six hundred and twenty-nine (61.5%) were successfully resolvedafter thrombolytic therapy while in 395 (38.5%) patients ST-segment could not resolve into 3conventional ST-segment resolution categories at 60 minute and 90 minute after thrombolysis. Threehundred and twelve (30%) and 444 (43.4%) with complete resolution, 344 (33.62%) and 325 (31.76%)with partial resolution, 367 (35.8%) and 491 (19.29%) were with no resolution at 60 and 90 minutesrespectively. Conclusion: Shock, congestive heart failure, and recurrent angina and ischemia occurredmore often in patientswith partial or no ST resolution as compare to complete resolution.Keywords: myocardial infarction, thrombolysis, ST-segment elevation, congestive heart failureReferences
Schröder K, Zeymer U, Wegschneider K, Schroder R. Prediction
of outcome in ST elevation myocardial infarction by the extent of
ST segment deviation recovery. Which method is best? [in
German] Z Kardiol 2004;93:595–604.
Nable JV, Brady W. The evolution of electrocardiographic changes
in ST-segment elevation myocardial infarction. Am J Emerg Med
;27:734–46.
Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S,
Wiviott SD, et al. Extent of ST-segment resolution after
fibrinolysis adds improved risk stratification to clinical risk score
for ST-segment elevation myocardial infarction. Am Heart J
;59(1):55–62.
De Lemos JA, Braunwald E. ST segment resolution as a tool for
assessing the efficacy of reperfusion therapy. J Am Coll Cardiol
;38:1283–94.
Testa L, van Gaal WJ, Biondi-Zoccai GG, Abbate A, Agostoni P,
Bhindi R, et al. Repeat thrombolysis or conservative therapy vs.
rescue percutaneous coronary intervention for failed thrombolysis:
systematic review and meta-analysi QJM 2008;101:387–95.
Bata I, Armstrong PW, Westerhout CM, Travers A, Sookram S,
Caine E, et al. WEST Study Group. Time from first medical
contact to reperfusion in ST elevation myocardial infarction: a
Which Early ST Elevation Myocardial Infarction Therapy (WEST)
substudy. Can J Cardiol 2009;25:463–8.
Pereira JL, Sakae TM, Machado MC, Castro CM.TIMI risk score
for acute myocardial infarction according to prognostic
stratification. Arq Bras Cardiol 2009;93(2):105–12.
De Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe
CH, Cutler SS, et al. Comparison of a 60 vs 90 minute
determination of ST-segment resolution after thrombolytic therapy.
J Am Coll Cardiol 2000;86:1235–7.
Lachance P, Déry JP, Beaudoin J, Barbeau GE, Noël B, Bertrand
OF, et al. ECG-guided immediate intervention at the time of
primary PCI to reduce door-to-balloon time in ST-elevation
myocardial infarction patients. J Invasive Cardiol 2008;20:623–6.
Parmley WW. Cost-effectiveness of reperfusion strategies. Am
Heart J 1999;138(2 Pt 2):S142–52.
Topol EJ, Ohman EM, Armstrong PW, Wilcox R, Skene AM,
Aylward P, et al. Survival outcomes 1 year after reperfusion
therapy with either alteplase or reteplase for acute myocardial
infarction: results from the Global Utilization of Streptokinase and
t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102:1761–5.
Banerjee A, Chisti Y, Banerjee UC. Streptokinase--a clinically
useful thrombolytic agent. Biotechnol Adv 2004;22:287–307.
Kauffmann QR. Timing is crucial in acute myocardial infarction.
Rev Med Chil 2008;136:1095–7.
Suri A, Ahsan S, Lim J, Cusack TP, Chua TP, Leatham EW. Early
administration of thrombolysis can prevent myocardial necrosis:
time is myocardium. Emerg Med J 2009;26:541–2.
Danchin N. Systems of care for ST-segment elevation myocardial
infarction: impact of different models on clinical outcomes. JACC
Cardiovasc Interv 2009;2:901–8.
Kostić T, Perisić Z, Milić D, Apostolović S, Martinović SS,
Bozinović N, et al. Coronary flow and hemorrhagic complications
after alteplase and streptokinase administration in patients with
acute myocardial infarction. Vojnosanit Pregl 2009;66:218–22.
Giraldez RR, Wiviott SD, Nicolau JC, Mohanavelu S, Morrow
DA, Antman EM, et al. Streptokinase and enoxaparin as an
alternative to fibrin-specific lytic-based regimens: an ExTRACTTIMI 25 analysis. Drugs 2009;69:1433–43.
Geltman EM. Coronary thrombolysis with intravenous
streptokinase. Cardiol Clin 1987;5(1):91–9.
Tatu-Chiţoiu G, Teodorescu C, Dan M, Guran M, Căpraru P,
Istrăţescu O, et al. Streptokinase-induced hypotension has no
detrimental effect on patients with thrombolytic treatment for acute
myocardial infarction. A substudy of the Romanian Study for
Accelerated Streptokinase in Acute Myocardial Infarction (ASKROMANIA). Rom J Intern Med 2004;42:557–73.
Brueck M, Bandorski D, Kramer W, Vogt PR, Heidt MC. The late
open infarct-related artery hypothesis: evidence-based medicine or
not? Clin Cardiol 2007;30:541–5.
Centurión OA. The open artery hypothesis: beneficial effects and
long-term prognostic importance of patency of the infarct-related
coronary artery. Angiology 2007;58:34–44.
Jensen-Urstad M, Samad BA, Jensen-Urstad K, Hulting J, Ruiz H,
Bouvier F, et al. Risk assessment in patients with acute myocardial
infarction treated with thrombolytic therapy. J Intern Med
;249:527–37.
Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S,
Rozenman Y, et al. Prevention of myocardial damage in acute
myocardial ischemia by early treatment with intravenous
streptokinase. N Engl J Med 1985;313:1384–9.
Purcell IF, Newall N, Farrer M. Change in ST segment elevation
minutes after thrombolytic initiation predicts clinical outcome as
accurately as later electrocardiographic changes. Heart
;78:465–71.
Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P,
Abildgaard U, et al. The Danish multicentre randomized study of
fibrinolytic therapy vs. primary angioplasty in acute myocardial
infarction outcome after 3 years follow-up. Eur Heart J
;29:1259–66
Downloads
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
